Physician profile
Ajit Vyas
NPI 1114152279
$2,796.95
in general payments reported to CMS, 2019-2025
8 companies · $945 in 2025
The $945 reported for 2025 was more than what 84% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $17.48 · 2022: $862 · 2023: $706 · 2024: $267 · 2025: $945.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,159 · Travel and Lodging: $759.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,159.31 |
| Travel and Lodging | $758.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,131.13 | 2022-2025 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Histosonics, INC. | $796.97 | 2025 | |
| Angiodynamics, INC. | $531.81 | 2023-2024 | Nanoknife, Solero |
| Abbott Laboratories | $127.97 | 2023 | Jeti |
| Inari Medical, INC. | $101.54 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Trisalus Life Sciences, INC. | $52.84 | 2025 | Trinav Infusion System |
| Ethicon US, LLC | $37.21 | 2025 | Neuwave |
| Merck Sharp & Dohme LLC | $17.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajit Vyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.